Pfizer Inc (NYSE: PFE) has reported earnings for its second fiscal quarter (ending June 30) of $0.01 versus $0.41 for the same period a year ago. E.P.S. were $-0.45 for the latest four quarters through June 30 versus $3.83 for the same period a year ago.
Recent Price Action
On 7/30/24, Pfizer Inc (NYSE: PFE) stock enjoyed a large increase of 2.2%, closing at $31.39. Moreover, trading volume in this advance was exceptionally high at 258% of normal. Relative to the market the stock has been weak over the last nine months but has risen 6.0% during the last week.
Current PriceTarget Research Rating
PFE is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Pfizer has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Pfizer has a good Appreciation Score of 74 but a slightly negative Power Rating of 35, with the Neutral Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment